These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 2818657

  • 1. Factor B activation products in patients with systemic lupus erythematosus. A marker of severe disease activity.
    Kerr LD, Adelsberg BR, Schulman P, Spiera H.
    Arthritis Rheum; 1989 Nov; 32(11):1406-13. PubMed ID: 2818657
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Activation of the alternative complement pathway accompanies disease flares in systemic lupus erythematosus during pregnancy.
    Buyon JP, Tamerius J, Ordorica S, Young B, Abramson SB.
    Arthritis Rheum; 1992 Jan; 35(1):55-61. PubMed ID: 1731815
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of alternative pathway and factor B haemolytic activities in patients with systemic lupus erythematosus: correlations with the alternative pathway regulatory proteins.
    Aguado MT, Perrin LH, Ramirez R, Miescher PA, Lambert PH.
    Clin Exp Immunol; 1980 Dec; 42(3):495-505. PubMed ID: 6163579
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Correlation of the activation of the fourth component of complement (C4) with disease activity in systemic lupus erythematosus.
    Senaldi G, Makinde VA, Vergani D, Isenberg DA.
    Ann Rheum Dis; 1988 Nov; 47(11):913-7. PubMed ID: 3264693
    [Abstract] [Full Text] [Related]

  • 7. Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.
    Mayes JT, Schreiber RD, Cooper NR.
    J Clin Invest; 1984 Jan; 73(1):160-70. PubMed ID: 6418767
    [Abstract] [Full Text] [Related]

  • 8. Relative importance of C3b inactivator and beta 1H globulin in the modulation of the properdin amplification loop in systemic lupus erythematosus.
    Whaley K, Schur PH, Ruddy S.
    Clin Exp Immunol; 1979 Jun; 36(3):408-14. PubMed ID: 114347
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Utilization of complement testing in clinical medicine.
    Abdul-Aziz K, Faizal AA.
    Saudi Med J; 2006 Nov; 27(11):1775-7. PubMed ID: 17106567
    [No Abstract] [Full Text] [Related]

  • 13. Complement activation before, during and after cardiopulmonary bypass.
    Bonser RS, Dave JR, John L, Gademsetty MK, Carter PG, Davies E, Taylor P, Gaya H, Lennox SC, Vergani D.
    Eur J Cardiothorac Surg; 1990 Nov; 4(6):291-6. PubMed ID: 2361017
    [Abstract] [Full Text] [Related]

  • 14. Complement Activation in Patients With Probable Systemic Lupus Erythematosus and Ability to Predict Progression to American College of Rheumatology-Classified Systemic Lupus Erythematosus.
    Ramsey-Goldman R, Alexander RV, Massarotti EM, Wallace DJ, Narain S, Arriens C, Collins CE, Saxena A, Putterman C, Kalunian KC, O'Malley T, Dervieux T, Weinstein A.
    Arthritis Rheumatol; 2020 Jan; 72(1):78-88. PubMed ID: 31469249
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Neutrophil chemotaxis and serum chemotactic activity in systemic lupus erythematosus.
    Alvarez I, Vazquez JJ, Fontan G, Gil A, Barbado J, Ojeda JA.
    Scand J Rheumatol; 1978 Jan; 7(2):69-74. PubMed ID: 705269
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.